Any current/future capex/capital investment/strategic investment?

The company is executing two main CAPEX projects: - **Baroda Brownfield Project**: Expected to be commissioned by the end of Q4 FY24. - **Mahad Greenfield Project**: A multi-product plant, on track for completion and commissioning by end of Q4 FY24. Initial CAPEX investment for Mahad is approximately INR 120 crores. Total CAPEX planned for next 3-5 years was earlier INR 350-400 crores; currently, 120 crores has been spent, with further decisions pending based on future progress. Commissioning timelines suggest new plants will require 2 to 3 quarters post-commissioning for meaningful contri

Future growth expectations in sales/revenue/volumes?

New plant commissioning requires 2 to 3 quarters post-commissioning to start meaningful contribution to sales and volumes. Brownfield projects integrate faster due to existing infrastructure; Greenfield projects follow multiple commercial batches before full-scale production. Management aims for 100% utilization of new capacities to maximize sales. Specialty aroma ingredients division shows healthy demand pickup, indicating growth potential. Fragrance and flavor verticals show improved contributions; bulk chemicals and camphor under pressure but positive. Production volumes have grown in doubl

Future growth expectations in earnings/operating earnings/profits/EPS?

New Brownfield (Baroda) and Greenfield (Mahad) plants to be commissioned by end of Q4 FY24, expected to contribute meaningfully 2 to 3 quarters post commissioning. Management aims for 100% utilization at scaled-up plants within 3 quarters after commissioning. Expect steady EBITDA margin guidance of 10-12% in the near to medium term; previous peaks above 20% were one-off instances primarily driven by camphor market dynamics. Specialty aroma ingredients division is witnessing healthy demand pickup, supporting volume growth. Fragrance and flavor vertical showing improved contributions; camphor an

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Aromatics Limited. Management discusses new plant commissioning timelines and stabilization period of 2 to 3 quarters before meaningful contributions to revenue. They expect between 200 to 300 days for new plants to get customer approvals and be incorporated into RFQs. There is a focus on accelerating customer acceptance through multiple commercial batches before full plant commercial production. No specific quantitative data on order book or pending orders is provided in the discussed

Oriental Aromat.Q3 FY24Chemicals & Petrochemicals

Oriental Aromat. Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹532P/E: 337.6Market Cap: ₹1.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

New plant commissioning requires 2 to 3 quarters post-commissioning to start meaningful contribution to sales and volumes.
Brownfield projects integrate faster due to existing infrastructure; Greenfield projects follow multiple commercial batches before full-scale production.
Management aims for 100% utilization of new capacities to maximize sales.
Specialty aroma ingredients division shows healthy demand pickup, indicating growth potential.
Fragrance and flavor verticals show improved contributions; bulk chemicals and camphor under pressure but positive.
Production volumes have grown in double digits across divisions recently.
Demand recovery expected in specialty chemicals and camphor divisions over the next few quarters.
Overall, growth in sales and volumes is expected as new capacities come online and demand improves, especially in aroma chemicals and fragrances.

Margin guidance

Category 3

New Brownfield (Baroda) and Greenfield (Mahad) plants to be commissioned by end of Q4 FY24, expected to contribute meaningfully 2 to 3 quarters post commissioning.
Management aims for 100% utilization at scaled-up plants within 3 quarters after commissioning.
Expect steady EBITDA margin guidance of 10-12% in the near to medium term; previous peaks above 20% were one-off instances primarily driven by camphor market dynamics.
Specialty aroma ingredients division is witnessing healthy demand pickup, supporting volume growth.
Fragrance and flavor vertical showing improved contributions; camphor and bulk chemicals currently under pressure but remain positive contributors.
Management endeavors to reduce new product stabilization and approval time, aiming to accelerate revenue contribution post-capex.
Overall, cautious but positive outlook on earnings growth with ramp-up in new capacities and improving product acceptance.

See what Oriental Aromat. management said on margin guidance — free account, 30 seconds.

Fundraise plans

- No explicit mention of any current or future fundraising plans through debt or equity during the call. - The company has already invested approximately Rs. 120 crores as part of its CAPEX plans for Mahad and Baroda projects. - Management indicated a wait-and-watch approach for further CAPEX beyond these projects, implying no immediate plans for additional fundraising. - Net debt-to-equity ratio was stable at 0.3x, showing manageable leverage and no urgent need to raise funds. - No specific comments on issuing new equity or taking on fresh debt were made in the call. Overall, the company appears focused on commissioning existing CAPEX without announcing new fundraising through debt or equity at this time.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Aromatics Limited.
Management discusses new plant commissioning timelines and stabilization period of 2 to 3 quarters before meaningful contributions to revenue.
They expect between 200 to 300 days for new plants to get customer approvals and be incorporated into RFQs.
There is a focus on accelerating customer acceptance through multiple commercial batches before full plant commercial production.
No specific quantitative data on order book or pending orders is provided in the discussed pages.

See what Oriental Aromat. management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is executing two main CAPEX projects:
- Baroda Brownfield Project: Expected to be commissioned by the end of Q4 FY24.
- Mahad Greenfield Project: A multi-product plant, on track for completion and commissioning by end of Q4 FY24.
Initial CAPEX investment for Mahad is approximately INR 120 crores.
Total CAPEX planned for next 3-5 years was earlier INR 350-400 crores; currently, 120 crores has been spent, with further decisions pending based on future progress.
Commissioning timelines suggest new plants will require 2 to 3 quarters post-commissioning for meaningful contribution to revenues and profitability.
Management aims for 100% utilization post scale-up.
The Greenfield Mahad plant's top-line generation is expected at around 0.7x of the asset cost, while Brownfield projects can range 1x to 1.5x turnover ratio.
CAPEX plans are strategically paced, with management monitoring market conditions before further investments.

Track Oriental Aromat. — get its next earnings analysis in your feed

How does Oriental Aromat. rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisOriental Aromat.

Rev 4Mar 3

See where Oriental Aromat. sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Oriental Aromat. rank in Chemicals & Petrochemicals?

Compare Oriental Aromat. against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Oriental Aromat.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →